アルツハイマー病治療薬の世界市場予測および分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 - Event-Driven Update

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 15
1.2 List of Figures 21
2 Introduction 24
2.1 Catalyst 24
2.2 Related Reports 25
2.3 Upcoming Related Reports 25
3 Disease Overview 26
3.1 Etiology and Pathophysiology 26
3.1.1 Etiology 27
3.1.2 Pathophysiology 29
3.2 Disease Staging Systems 38
3.3 Symptoms 41
3.4 Prognosis 43
3.5 Quality of Life 43
4 Epidemiology 45
4.1 Disease Background 45
4.2 Risk Factors and Comorbidities 46
4.2.1 A family history of Alzheimer’s increases the risk of developing the disease by 7.5 times 47
4.2.2 The APOE ε4 allele triples the risk for AD 48
4.2.3 Cardiovascular risk factors in midlife significantly increase the risk of developing AD in later life 48
4.2.4 The incidence and prevalence of AD double every five years after age 65 years 49
4.2.5 Diabetes doubles the risk of AD in men, but only marginally affects the risk in women 49
4.2.6 Women are 1.5 times more likely to develop AD than men 50
4.2.7 Depression triples the risk for AD, and is the most common comorbidity 50
4.2.8 Up to 70% of AD patients also suffer from anxiety 51
4.2.9 Psychosis and agitation are common comorbidities in Alzheimer’s patients 51
4.3 Global Trends 51
4.3.1 US 52
4.3.2 5EU 53
4.3.3 Japan 55
4.3.4 China 56
4.3.5 India 56
4.4 Forecast Methodology 57
4.4.1 Sources Used 62
4.4.2 Forecast Assumptions and Methods 69
4.4.3 Sources Not Used 79
4.5 Epidemiology Forecast (2013-2023) 81
4.5.1 Total Prevalent Cases of AD 81
4.5.2 Age-Specific Total Prevalent Cases of AD 83
4.5.3 Sex-Specific Total Prevalent Cases of AD 85
4.5.4 Age-Standardized Total Prevalence of AD 88
4.5.5 Total Prevalent Cases of AD, by Severity 89
4.5.6 Total Prevalent Cases of MCI 91
4.5.7 Age-Specific Total Prevalent Cases of MCI 93
4.5.8 Sex-Specific Total Prevalent Cases of MCI 95
4.5.9 Age-Standardized Total Prevalence of MCI 98
4.6 Discussion 99
4.6.1 Conclusions Regarding the Epidemiological Trends 99
4.6.2 Limitations of the Analysis 101
4.6.3 Strengths of the Analysis 102
5 Disease Management 103
5.1 Diagnosis Overview 103
5.1.1 Probable AD Dementia 106
5.1.2 Preclinical AD 107
5.1.3 MCI 108
5.2 Treatment Overview 110
5.3 Clinical Practice 112
5.3.1 Leading Prescribed Therapies 114
5.4 US 115
5.5 France 118
5.6 Germany 120
5.7 Italy 122
5.8 Spain 124
5.9 UK 126
5.10 Japan 129
5.11 China 131
5.12 India 133
6 Competitive Assessment 135
6.1 Overview 135
6.2 Product Profiles – Major Brands 136
6.2.1 Aricept (donepezil hydrochloride) 136
6.2.2 Exelon (rivastigmine, rivastigmine tartrate) 141
6.2.3 Razadyne (galantamine hydrobromide) 146
6.2.4 Namenda (memantine hydrochloride) 151
6.3 Other Drugs/Classes 157
7 Unmet Need and Opportunity 159
7.1 Overview 159
7.2 Drugs with Disease-Modifying Mechanisms of Action 160
7.2.1 Unmet Need 160
7.2.2 Gap Analysis 161
7.2.3 Opportunity 162
7.3 Diagnosis in the Prodromal or Presymptomatic Stages 163
7.3.1 Unmet Need 163
7.3.2 Gap Analysis 164
7.3.3 Opportunity 165
7.4 Improved Control of Symptoms 166
7.4.1 Unmet Need 166
7.4.2 Gap Analysis 167
7.4.3 Opportunity 168
7.5 Easier Access to Treatment 169
7.5.1 Unmet Need 169
7.5.2 Gap Analysis 169
7.5.3 Opportunity 170
8 Pipeline Assessment 172
8.1 Overview 172
8.2 Clinical Trial Mapping 173
8.2.1 Clinical Trials by Class 173
8.3 Promising Drugs in Clinical Development 174
8.3.1 Biopharmaceutical Products 176
8.3.2 Small Molecule 209
8.3.3 Other Drugs in Development 258
9 Current and Future Players 260
9.1 Overview 260
9.2 Trends in Corporate Strategy 261
9.3 Company Profiles 262
9.3.1 Actavis 262
9.3.2 Lundbeck 265
9.3.3 Eisai 268
9.3.4 Pfizer 270
9.3.5 Novartis 272
9.3.6 Roche 274
9.3.7 Eli Lilly 276
9.3.8 Merck & Co. 280
9.3.9 AstraZeneca 281
9.3.10 Takeda 283
10 Market Outlook 286
10.1 Global Markets 286
10.1.1 Forecast 286
10.1.2 Drivers and Barriers – Global Issues 294
10.2 United States 297
10.2.1 Forecast 297
10.2.2 Key Events 301
10.2.3 Drivers and Barriers 302
10.3 France 305
10.3.1 Forecast 305
10.3.2 Key Events 308
10.3.3 Drivers and Barriers 309
10.4 Germany 312
10.4.1 Forecast 312
10.4.2 Key Events 315
10.4.3 Drivers and Barriers 315
10.5 Italy 317
10.5.1 Forecast 317
10.5.2 Key Events 321
10.5.3 Drivers and Barriers 321
10.6 Spain 323
10.6.1 Forecast 323
10.6.2 Key Events 327
10.6.3 Drivers and Barriers 327
10.7 United Kingdom 329
10.7.1 Forecast 329
10.7.2 Key Events 332
10.7.3 Drivers and Barriers 333
10.8 Japan 335
10.8.1 Forecast 335
10.8.2 Key Events 339
10.8.3 Drivers and Barriers 339
10.9 China 341
10.9.1 Forecast 341
10.9.2 Key Events 345
10.9.3 Drivers and Barriers 345
10.10 India 347
10.10.1 Forecast 347
10.10.2 Key Events 350
10.10.3 Drivers and Barriers 350
11 Appendix 353
11.1 Bibliography 353
11.2 Abbreviations 378
11.3 Methodology 388
11.4 Forecasting Methodology 388
11.4.1 Diagnosed AD Patients 388
11.4.2 Percent Drug-Treated Patients 389
11.4.3 Drugs Included in Each Therapeutic Class 389
11.4.4 Launch and Patent Expiry Dates 390
11.4.5 General Pricing Assumptions 391
11.4.6 Compliance Assumptions 392
11.4.7 Individual Drug Assumptions 394
11.4.8 Generic Erosion 400
11.4.9 Pricing of Pipeline Agents 400
11.5 Primary Research – KOLs Interviewed for This Report 402
11.6 Primary Research – Prescriber Survey 403
11.7 About the Authors 404
11.7.1 Analyst 404
11.7.2 Therapy Area Director 404
11.7.3 Epidemiologist 405
11.7.4 Global Head of Healthcare 405
11.8 About GlobalData 406
11.9 Disclaimer 406


【レポート販売概要】

■ タイトル:アルツハイマー病治療薬の世界市場予測および分析
■ 英文:PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 - Event-Driven Update
■ 発行日:2015年5月1日
■ 調査会社:GlobalData
■ 商品コード:GDHC010EPIDR
■ 調査対象地域:グローバル
  • セキュリティテストサービスの世界市場2015-2019
    About Security Testing Companies around the world are witnessing unprecedented dependence on technology to run their business and drive revenue growth. With more and more business functions being enabled and enriched by innovative IT applications and solutions, IT security has become more crucial. In addition, ensuring a secure infrastructure has become a top priority for business organizations. I …
  • リビアの石油・ガス産業における中流(Midstream)市場展望
    Libya Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Oil Storage, Pipelines and Gas Processing Summary "Libya Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Oil Storage, Pipelines and Gas Processing" is a comprehensive report on midstream oil and gas industry in Libya. The report provides oil and natural gas production, consumption and exports from 2000 …
  • 医療放射線検出・モニタリング・安全機器の世界市場予測(~2021):ガス充填型検出器、ガイガーミュラー、サーベイメーター、固体検出器
    The global medical radiation detection, monitoring, and safety market is expected to reach USD 1,215.4 Million by 2021 from USD 887.0 Million in 2016, at a CAGR of 6.5% from 2016 to 2021. This market is segmented based on detectors, detection and monitoring products, safety products, end users, and regions. Growth in the medical radiation detection and monitoring market is mainly driven by factors …
  • 避妊用具/避妊剤のグローバル市場(2014-2018)
    About Contraceptives Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods include male sterilization (vasectomy), and female sterilization including tubal occlusion or hys …
  • SCADA(監視制御とデータ収集)のグローバル市場(2013 – 2020)
    Supervisory Control and Data Acquisition (SCADA) is an industrial control system that is used to gather data from sensors and instruments located at remote sites and then transmit and display this data at a central site for controlling or monitoring purposes. They are also used to collect and analyze data on real-time basis. The high potential from renewable energy and high investments in infrastr …
  • フリードライヒ運動失調症(Friedreich Ataxia):世界の治験レビュー(2015年上半期版)
    Friedreich Ataxia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H1, 2015" provides data on the Friedreich Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Friedreich Ataxia. It includes an overview of the trial numbers and their recruitment s …
  • Celiac Disease:グローバル臨床試験レビューH1, 2013
    Celiac Disease Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Celiac Disease Global Clinical Trials Review, H1, 2013" provides data on the Celiac Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Celiac Disease. It includes an overview of the trial numbers and their recruitment status as per …
  • 世界の石油・ガスアキュムレータ市場2015
    The Global Oil & Gas Accumulator Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Oil & Gas Accumulator industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Oil & Gas Accumulator market analysis is provided for the international markets including deve …
  • 世界の水力電力市場動向2013
    2013 Global Hydropower Market Update: Installations Up by 15% from 2012 Summary Annual installed capacity increased by 13.5% over 2012 from 34,608 Megawatts (MW) to 39,297 MW. China remained market leader in 2013, 14,967 MW of hydropower projects were installed in China, which accounted for 38.1% of global hydropower capacity additions. Hydropower installations in 2014 expected to decline by 6.4% …
  • 世界のHDアクションカメラ市場(2014-2018)
    About Action Cameras An action camera is a HD personal camera used in extreme action photography. It is used in unusual places such as mountains, underwater, air, cars, and army tanks. These cameras are hand-free and can be mounted anywhere on the body. Such cameras are popular with water sports enthusiasts, skiers, motorcyclists, drivers, and mountain bikers. TechNavio's analysts forecast the Glo …
  • デジタル・バラスト(安定器)の世界市場2016-2020
    About Digital Ballast Conventional farming methods are influenced by several factors, including weather, sunlight, temperature, and rainfall. Hence, it is difficult to guarantee a stable food supply through conventional farming. The yield in this model can be affected by natural disasters or the increasing shortage of cultivable land. Under these circumstances, vegetable factories that grow vegeta …
  • 鉄道車両用バッテリーの世界市場:電車用、貨車用、機関車用
    About Railway Batteries Railway batteries are generally used for rolling stock or stationary applications. Rolling stock batteries are used for starting locomotives, lightings, and on-board auxiliary systems used in engines and coaches; whereas, stationary batteries are used as emergency backup power for railroad crossings, signal towers, and signaling systems. Technavio’s analysts forecast the gl …
  • 水性塗料の世界市場:水性ペンキ、エマルジョン/ラテックス塗料、アルキド樹脂塗料
    About Waterborne Coatings Waterborne coatings are coatings in which water is used as a dispersal agent for the resin, thereby making these coatings environment friendly and easy to use. Water constitutes around 80 percent of the volume of the paint, with traces of other solvents such as glycol ethers. Because of their low VOC content, these coatings are gaining popularity in the US and Western Eur …
  • ソーシャルビジネスインテリジェンス(BI)の世界市場2016-2020
    About Social Business Intelligence Business intelligence software is an important tool or application used by organizations to analyze data and make improved real-time market decisions. Traditionally, business intelligence was used only for reporting, designing dashboards, and resolving queries. Its goal was to track key business performance and metrics. The main focus of traditional business inte …
  • 排熱回収ボイラ(HRSG)の世界市場2016-2020
    About Heat Recovery Steam Generator Fossil fuels account for more than 60% of the global electricity production. Depending on the fuel and the process used, the overall electricity energy conversion ranges between 35% and 40%. This implies that 55%-60% of the energy is wasted during the process. Large quantities of this wasted energy end up as thermal energy in the exhaust gases during the combust …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。